Spring Sale: Up to 50% OFF · Ends Tonight

Peptide Hair Serums: How They Work and What the Research Shows

Updated 2026-04-15 13 min read By Provant Labs Research Team

Hair growth peptides are short amino acid chains that interact with follicle cells to influence the hair cycle. Unlike oral supplements that take a systemic route to reach the scalp, topical peptide serums are applied directly to the follicle environment. Several specific peptides have genuine clinical data behind them, including a double-blind placebo-controlled RCT showing 71.5 new hairs per cm2 at 6 months. This guide examines the published research, explains the mechanisms, and is honest about where the evidence is strong versus where it's still emerging.

What Are Peptides and Why Do They Matter for Hair?

Peptides are short chains of amino acids, typically 2-50 residues long. They're naturally present throughout the body, where they function as signaling molecules: triggering cellular responses, activating receptors, and modulating growth factor activity.

For hair follicles specifically, certain peptides interact with dermal papilla cells (the command center at the base of each follicle) that control whether the hair is actively growing, transitioning, or resting. By mimicking or activating growth factor signals at the scalp level, peptides can influence how long follicles stay in the anagen (growth) phase and how effectively they respond after a disruption like telogen effluvium.

This is mechanistically different from minoxidil (which works primarily through vasodilation and ion channel activity) and from DHT blockers like finasteride or saw palmetto (which work by reducing the androgenic signal). Peptides work upstream, at the growth-factor signaling level.

The four primary growth factor pathways targeted by hair growth peptides:

Each of these growth factors has receptors on follicle cells. Biomimetic peptides that activate these receptors topically can, in theory, replicate some of the effects of the endogenous growth factors themselves.

The Clinical Evidence

GHK Copper Peptide: The Strongest Topical Data

GHK (glycyl-L-histidyl-L-lysine) is a copper-binding tripeptide that occurs naturally in human plasma, saliva, and urine, declining significantly with age. It was first identified in 1973, and its hair-related properties have been studied for decades.

The strongest standalone RCT for a topical peptide and hair: a 2016 double-blind, placebo-controlled trial (n=45, 6 months) testing a GHK-copper peptide formulation with 5-aminolevulinic acid (5-ALA). Results:

Zero adverse events. The low-dose outperforming the high-dose is consistent with copper peptide biology: copper can be pro-oxidative at high concentrations, so there's a sweet spot.

For context on scale: 71.5 new hairs per cm2 is a meaningful change. The average scalp has roughly 300-400 follicles per cm2. Gaining 71 per cm2 represents roughly a 20-25% increase in active follicle density. That's more than most oral supplements achieve in any published study.

Biomimetic Peptides: Rinaldi 2019

Rinaldi et al. 2019 (Journal of Dermatological Treatment, n=60, double-blind RCT) tested a topical biomimetic peptide formula. The results:

The placebo effect in hair studies is real and usually substantial. People perceive more hair, wash less aggressively, and handle it differently when they think they're using a treatment. The 68% vs 28% gap at 4 months represents a genuine treatment effect on top of the placebo baseline.

Peptide Serums for Telogen Effluvium: JCAS 2025

This one is specific to the condition most GLP-1 users are dealing with. A 2025 study in the Journal of Cosmetic and Aesthetic Surgery (JCAS, n=45 women with confirmed telogen effluvium) compared several interventions. The cytokine/peptide serum group showed a 54.6% reduction in hair shedding, the best-performing intervention in the study.

This is the data point that matters most for GLP-1-related TE, because it was tested specifically in TE patients rather than in people with androgenic alopecia or general thinning.

QR678 Neo Formulation (Contains sh-Polypeptides)

The QR678 Neo formula, which includes sh-polypeptides in its active complex, has been studied in a separate body of research. In published case series and clinical data: 83% of patients showed reduced hair loss on pull test, and at 1 year, statistically significant hair gain was documented with increased terminal hairs and decreased vellus hairs. The mechanistic signal here is meaningful: more thick, pigmented terminal hairs and fewer fine vellus hairs is the right direction for hair density.

Individual Peptides: What the Evidence Looks Like Up Close

It's worth being specific here, because peptide claims vary widely in how well they're supported.

sh-Polypeptide-9 (Biomimetic VEGF)

This peptide mimics vascular endothelial growth factor. Bassino et al. 2016 (Experimental Dermatology, University of Turin) published a co-culture study showing that sh-Polypeptide-9 stimulates paracrine interactions between endothelial cells and dermal papilla cells. This provides mechanistic evidence for perifollicular vascularization support. The study is peer-reviewed with 7-8 cross-database citations.

The caveat: it's an in vitro/co-culture study, not a topical RCT. The mechanism is plausible and well-characterized. Clinical translation to the human scalp has not been demonstrated in a standalone RCT for this specific peptide.

sh-Polypeptide-1 (KGF Mimic)

Keratinocyte growth factor drives outer root sheath keratinocyte proliferation. A registered clinical trial for a KGF Hair Serum exists (completed, randomized, placebo-controlled), published as an ASCO abstract in the context of chemotherapy-induced alopecia prevention. No full peer-reviewed paper with cosmetic-use outcomes is publicly available.

The appropriate claim level: "supports scalp environment during follicle stress." Not "prevents hair loss."

sh-Oligopeptide-2 (IGF-1 Mimic)

IGF-1 supports proliferation and survival pathways in dermal papilla cells. A recent review of topical IGF-1 treatments found signs of efficacy and safety with minimal systemic absorption, though delivery methods and long-term data are still developing. More evidence is needed before strong claims are appropriate.

GHK-Cu (Copper Peptide)

This has the best-characterized evidence base among all hair growth peptides. Beyond the 2016 RCT above, GHK-Cu has decades of research on wound healing, collagen synthesis, and tissue remodeling. The hair-specific mechanism: copper is essential for lysyl oxidase (which cross-links collagen and elastin in the follicle structural matrix) and for melanin production. GHK-Cu has also shown antioxidant properties, relevant because oxidative stress at the follicle level is a known contributor to premature cycling.

How Topical Delivery Works (and Why It Matters)

The standard objection to topical anything for hair is: "Doesn't it just sit on the surface?" Peptides are small enough to penetrate the stratum corneum when formulated correctly. The follicular infundibulum (the canal through which the hair shaft exits) provides a direct pathway for topical agents to reach the dermal papilla.

Molecular weight matters. Small peptides (under 500 Da) penetrate relatively well. GHK is 340 Da. Most bioactive hair peptides fall in the 500-1500 Da range, which is manageable with appropriate vehicle formulation (typically aqueous serums at slightly acidic pH to match the scalp's natural environment).

Oral delivery of the same peptides is essentially useless for hair follicles specifically: peptides are broken down to individual amino acids during digestion, losing their signaling specificity entirely. You'd need to eat the peptide to get the amino acids. But you don't get the signaling molecule. This is why oral "collagen peptides" work primarily by providing amino acid substrate, not by delivering intact peptide signals to follicles.

Peptides vs Minoxidil: An Honest Comparison

Minoxidil has more clinical data. It's been studied for decades, is FDA-approved, and its mechanism is well-established. That's the honest starting point.

The practical differences:

Minoxidil works continuously on blood vessel dilation and potassium channel activity. Stop using it, and you lose the gains within months. It was designed for androgenic alopecia, not telogen effluvium. Some women experience unwanted facial hair growth from topical minoxidil (hypertrichosis). And at 5%, it's not subtle. The scalp can get greasy, residue is visible.

Peptide serums work through growth factor signaling, which targets a different point in the hair cycle. They're appropriate for TE specifically, where the goal is supporting follicle recovery during the shedding phase, not managing a permanent androgenic condition. Stopping after recovery doesn't necessarily cause a rebound shed the way minoxidil discontinuation does.

Are they comparable in evidence quantity? No. Minoxidil wins on volume of data. But for TE specifically, the JCAS 2025 study is actually the right comparison because it was conducted in TE patients, not AGA patients. Minoxidil's approval is for AGA.

Saw Palmetto and Rosemary: The Supporting Cast

Peptide serums formulated for hair loss typically include additional botanical actives. Two have solid evidence.

Saw Palmetto (Serenoa repens)

Saw palmetto inhibits 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Topical application reduces local DHT without affecting serum DHT levels (Sudeep et al. 2023, n=80, 16 weeks): shedding down 22.19% (p<0.05), density up 7.61% (p<0.001). The systemic safety profile for topical saw palmetto is essentially clean.

For TE, saw palmetto is a supporting ingredient. It doesn't address the TE mechanism directly (which is follicle cycling disruption, not DHT). But it reduces a secondary androgenic signal that may be amplified during the follicle stress period, particularly in perimenopausal women where estrogen is already declining.

Rosemary Extract (Rosmarinus officinalis)

Panahi et al. 2015 (SKINmed, n=100, 6 months): rosemary oil vs minoxidil 2%, head-to-head. Both groups significantly improved from baseline. No significant difference between groups. This is the benchmark result for rosemary.

Patel et al. 2025 (Cureus, n=90, 90 days, double-blind, 3-arm) added to this: rosemary-lavender combination showed +57.73% growth rate, +68.70% hair thickness, ~32% density improvement, and more than 40% shedding reduction, all at p<0.0001.

The mechanism (5-alpha reductase inhibition at 82.4% in vitro per Murata et al. 2013) overlaps with saw palmetto, creating a potentially additive effect when combined.

The combination of peptides with topical saw palmetto and rosemary makes mechanistic sense: peptides address growth-factor signaling, saw palmetto and rosemary reduce the androgenic signal at the follicle level. They're working on different parts of the problem.

Who Benefits from Peptide Serums?

Peptide serums are best suited for:

Telogen effluvium from weight loss, GLP-1 use, postpartum, or stress. The JCAS 2025 TE-specific data is most relevant here. The goal is supporting follicle recovery during the shedding phase.

Women who want to avoid prescription treatments. No Rx needed, no systemic DHT suppression, no lifetime dependency.

People in the 3-9 month window after a TE trigger. This is when follicle support is most relevant. You're trying to shorten the shedding phase and support the quality of the recovery, not manage a permanent condition.

Peptide serums are less suited for:

Androgenic alopecia (AGA) as a standalone treatment. If the primary problem is pattern hair loss driven by DHT sensitivity and follicle miniaturization, minoxidil (or finasteride, for appropriate patients) has a much stronger evidence base.

Scar-tissue alopecia. If the follicle is destroyed by scarring, no topical treatment revives it. Topicals work on follicles that are present and functional but underperforming.

What to Expect Month by Month

This is worth saying plainly because a lot of people give up too early.

Hair follicles cycle slowly. The anagen (growth) phase takes months. When a follicle shifts from telogen back to anagen, the new hair shaft takes weeks to push through the scalp surface. You won't see results in the first 4 weeks of using a peptide serum. And if you're in active shedding when you start, you may not see a dramatic change until month 2-3.

Here's what the timeline typically looks like, based on the Rinaldi 2019 and JCAS 2025 data:

Weeks 1-4: No visible changes. This is normal. The serum is interacting with the follicle microenvironment, but hair shaft growth takes time.

Weeks 4-8: Some women notice slightly less shed hair in the drain. Not dramatic. Worth noting.

Months 2-3: The Rinaldi 2019 study showed 57% hair density improvement at 3 months versus 28% for placebo. If you're consistent, this is when you start noticing. The "baby hair" fuzz at the hairline is often the first visible sign.

Months 3-4: The JCAS 2025 data (54.6% shedding reduction) was measured at this timeframe. Meaningful density improvement. Less fallout, more visible new growth.

Months 4-6: Full-context improvement. This is the window where the hair cycle has had enough time to complete a partial reset.

The key variable is consistency. Applying a serum 2-3 times per week instead of daily extends the timeline proportionally. The follicle support needs to be ongoing during the shedding phase to have the intended effect.

Three Misconceptions About Peptide Serums

Misconception 1: "More peptides = better results."

Not accurate. Copper peptides are pro-oxidative at high concentrations. The 2016 GHK RCT actually found the lower dose outperformed the higher dose. Formulation matters more than concentration. The right peptides at appropriate concentrations in a suitable vehicle will outperform a high-peptide serum in the wrong base.

Misconception 2: "Peptide serums are just cosmetic, not therapeutic."

The regulatory classification is cosmetic, meaning no disease claims are permitted. But "cosmetic" doesn't mean ineffective. Minoxidil was initially studied as an oral antihypertensive before its topical use for hair was found to be therapeutic. The regulatory category reflects how the product is regulated, not whether the active ingredients have real biological effects. The RCT data says they do.

Misconception 3: "If it doesn't work in 30 days, it doesn't work at all."

This is the hair care industry's core timing problem. Most DTC hair products offer 30-day trials, which is not enough time to see changes in follicle cycling. The Rinaldi 2019 study ran 4 months. The GHK RCT ran 6 months. Evaluating a peptide serum at 30 days is like evaluating whether a seed grew by checking the soil a week after planting.

Reading Peptide Serum Labels

Not all peptide serums are equal. Things to check:

Specific peptide names on the ingredient list. Generic "peptide complex" without individual INCI names is a red flag. Look for: sh-Polypeptide-9, sh-Polypeptide-1, sh-Oligopeptide-2, GHK-Cu (copper tripeptide-1), acetyl tetrapeptide-3.

Peptides near the top of the list. Ingredients are listed in descending concentration order. A peptide serum where all the peptides appear after fragrance and preservatives probably has them at trace levels.

Appropriate vehicle. Aqueous serum at pH 4.5-5.5 (matching scalp pH) allows for better penetration than oil-based formulas.

No active ingredients that create interactions. Retinoids at high concentrations can disrupt peptide stability. Low pH (below 3.5) can denature some peptides.

The Product Context

The PD-5 Complex is a topical serum specifically formulated for GLP-1-related shedding. It combines five bioactive peptides (including sh-Polypeptide-9 and sh-Oligopeptide-2) with topical saw palmetto and rosemary extract, applied directly to the scalp. The formulation follows a scalp-first principle: put the actives at the follicle level rather than routing them through a systemic oral pathway.

It's not a cure. It doesn't claim to be. It's a topical support tool for the follicle environment during the shedding and recovery phases of TE.

For more context on TE treatment options: Telogen effluvium treatment: what the research shows.

For the GLP-1-specific picture: GLP-1 hair loss: the complete guide.

FAQ

Do peptide serums actually work for hair growth?

The clinical data is genuine but limited in scale. The strongest evidence: a 2016 double-blind RCT (n=45) found +71.5 hairs per cm2 for a GHK peptide formula. Rinaldi et al. 2019 (n=60) found 68% density improvement at 4 months versus 28% placebo. A 2025 JCAS study in TE patients found 54.6% shedding reduction. These are real results from real trials. The evidence base is smaller than minoxidil's, but it exists.

What peptides are most effective for hair loss?

GHK-Cu has the best-characterized evidence base, supported by decades of research and a dedicated RCT. Biomimetic growth factor peptides (sh-Polypeptide-9 for VEGF mimicry, sh-Polypeptide-1 for KGF mimicry, sh-Oligopeptide-2 for IGF-1 mimicry) have mechanistic evidence and some clinical data, though the individual RCTs are less rigorous. The combination of multiple peptides targeting different growth factor pathways is the current best practice.

How long before a peptide serum shows results?

Based on the Rinaldi 2019 and JCAS 2025 data, meaningful results typically appear at 3-4 months. The hair cycle itself requires this time: follicles transitioning back into anagen take weeks to produce visible shaft growth. Don't expect results in 4 weeks. The 90-day window is the minimum meaningful evaluation period.

Can I use a peptide serum with minoxidil?

Generally yes, there's no known interaction between peptide serums and minoxidil. But this is worth confirming with a dermatologist, particularly if you're also using other actives like retinoids or high-concentration acids on your scalp.

Are peptide serums safe during GLP-1 treatment?

Topical peptide serums are cosmetic-grade and applied to the scalp, not ingested. There are no known interactions with semaglutide, tirzepatide, or other GLP-1 receptor agonists. That said, confirm with your prescribing provider if you have any concerns.

How are peptide serums different from biotin for hair loss?

Biotin is a B-vitamin taken orally. Multiple dermatology reviews have found no benefit from biotin supplementation for people with normal biotin levels. Peptide serums are applied topically to the scalp and interact directly with follicle cells through growth-factor signaling pathways. They're different mechanisms entirely. The topical route also bypasses the absorption and distribution limitations of oral delivery.

Ready to support your hair during your GLP-1 journey?

See the PD-5 Complex